Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial-Reference-Cited by-同舟云学术

Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial

Published:2024-05 Issue:5 Volume:6 Page:e268-e278
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Kjørholt Kaja E,Sundlisæter Nina Paulshus,Aga Anna-Birgitte,Sexton Joseph,Olsen Inge C,Fremstad Hallvard,Spada Cristina,Madland Tor Magne,Høili Christian A,Bakland Gunnstein,Lexberg Åse,Hansen Inger Johanne Widding,Hansen Inger Myrnes,Haukeland Hilde,Ljoså Maud-Kristine Aga,Moholt Ellen,Uhlig Till,Kvien Tore K,Solomon Daniel H,van der Heijde Désirée,Haavardsholm Espen A,Lillegraven Siri

Funder

South-Eastern Norway Regional Health Authority

Research Council of Norway

Publisher

Elsevier BV

Reference30 articles.

1. Rheumatoid arthritis;Smolen;Lancet,2016

2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update;Smolen;Ann Rheum Dis,2023

3. Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trial;van Mulligen;Ann Rheum Dis,2020

4. 2021 American college of rheumatology guideline for the treatment of rheumatoid arthritis;Fraenkel;Arthritis Care Res (Hoboken),2021

5. Etanercept or methotrexate withdrawal in rheumatoid arthritis patients in sustained remission;Curtis;Arthritis Rheumatol,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tapering conventional synthetic DMARDs towards sustained drug-free remission in rheumatoid arthritis;The Lancet Rheumatology;2024-05